About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Cohance Lifesciences Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Neuland Laboratories
18082.15
880.55
5.12
283.01
63.89
3797
46.71
0.19
1182.3
Gland Pharma
2298.6
113.45
5.19
78.78
29.18
60814
31.82
0.87
592.08
Venus Remedies
1765.55
69.55
4.1
74.3
23.76
5260
311.41
0.57
441.01
CORONA Remedies
1914.05
66.35
3.59
30.22
63.33
7646
0.52
121.97
Sanofi India
3411.05
61.85
1.85
134.52
25.36
2475
-43.41
3.61
294.48
Torrent Pharma
4514.15
56.4
1.27
64.75
69.71
32831
42.62
0.84
249.72
Alkem Laboratories
5411.25
44.85
0.84
182.76
29.61
77494
13.6
0.98
1030.68
Laurus Labs
1480.8
44.6
3.11
13.71
108.04
207575
122.14
0.14
96.82
Shilpa Medicare
590.55
44.6
8.17
6.8
86.86
155909
34.03
0.1
276.16
Aurobindo Pharma
1535.5
43.2
2.89
41.97
36.59
116113
39.62
0.26
353.55
Alivus Life Sciences
1118.05
35.55
3.28
45.99
24.31
42066
12.16
0.45
229.11
Aarti Pharmalabs
711.05
33.7
4.98
19.44
36.58
74065
-18.51
0.49
203.25
Glaxosmithkline Phar
2397.9
32.35
1.37
59.73
40.15
23015
-24.34
2.38
133.22
Supriya Lifescience
958.5
31.55
3.4
25.98
36.89
23544
42.45
0.1
123.84
Orchid Pharma
988.2
29.25
3.05
8.91
110.87
10805
44.84
0
261.06
Pfizer
4497.65
28.15
0.63
157.92
28.48
3079
-20.25
1.67
921.84
Panacea Biotec
552.5
27.75
5.29
-4.88
0
54023
33.13
0
51.26
Zydus Lifesciences
1112.1
27.75
2.56
35.69
31.16
144784
16.7
0.09
210.64
JB Chem & Pharma
2234.8
26.5
1.2
41.98
53.23
6149
24.34
0.98
251.48
Eris Lifesciences
1459.8
26.05
1.82
17.61
82.88
3495
-10.08
0.49
183.9
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Scores
|
Policies of JFSL
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
|
Rights and obligation
|
SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.